Coffin Mew advises Amethyst Radiotherapy on UK expansion
Coffin Mew has advised Amethyst Radiotherapy, Europe’s fastest growing private cancer treatment institution, on its expansion into the UK through the acquisition of Medical Equipment Solutions Limited (MESL).
MESL is a specialist provider of intracranial radiation treatments using the Gamma Knife* platform, a non-invasive stereotactic radiosurgery platform that involves no scalpel or incision. With two centres in the UK, the Queen Square Radiosurgery Centre in London and the Thornbury Radiosurgery Centre in Sheffield, MESL is a key NHS partner in the delivery of specialist radiotherapy treatments.
Amethyst Group is a privately-owned healthcare institution, whose owners have been active in the healthcare and pharma markets in Europe for the past 20 years. The group now operates 12 radiotherapy centres across six countries with a further 20 either in planning and/or development.
Group CEO, Ludovic Robert, says: “Amethyst Radiotherapy aims to build on the established reputation of Queen Square Radiosurgery Centre, London, and the Thornbury Radiosurgery Centre in Sheffield to provide the best possible evidence-based treatment for patients with previously hard to treat brain lesions.
“Amethyst is rigorously focused on delivering the highest quality of service for patients, working in close partnership with leading NHS Centres of Excellence, neurosurgeons and oncologists as well as private payors and providers across the wider health economy.”
Amethyst expects to further develop its service footprint across the UK. Amethyst Radiotherapy has appointed Stefan Doroszkowski to lead the UK business roll-out. Stefan has worked for over 25 years across the industry for a wide range of public and private payors and providers.
Stefan Doroszkowski said: “We enjoyed working with Dominic and the multi-disciplinary Coffin Mew team and look forward to expanding our operations in the UK.”
The multi-disciplinary Coffin Mew team acting for Amethyst Radiotherapy on this transaction was led by corporate partner Dominic Travers, with support from commercial and IP specialists Mark O’Halloran and Guy Cartwright, employment expert Amy Richardson, and commercial property advice from Hannah Bassett.
Amethyst Radiotherapy was also advised on this transaction by Shipleys and Enumerate.
Dominic Travers, corporate partner at Coffin Mew said: “We were pleased to have helped Amethyst Radiotherapy with this strategic acquisition and look forward to supporting the company with its growth plans to bring cutting edge treatments to patients throughout the UK.”
*Gamma Knife is a registered trade mark of Elekta. All rights reserved.